Aura Biosciences Target Price

Analysts' average 12-month price target for Aura Biosciences is $18.

Get informed when a big investor buys or sells

+ Follow

Share Price

$7.9

Average Target Price

$17.50

121.5% upside

2 analysts in the last 4 months

High: $18 | Low: $17

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-11	H.C. Wainwright	$18	127.8% upside
2026-05-12	Leerink Partners	$17	115.2% upside
2025-03-26	JMP SecuritiesJonathan Wolleben	$19	140.5% upside
2025-03-25	H.C. WainwrightEdward White	$25	216.5% upside
2024-10-18	ScotiabankGeorge Farmer	$23	191.1% upside
2024-10-18	H.C. WainwrightEd White II	$22	178.5% upside
2024-10-18	BTIGJulian Harrison	$24	203.8% upside
2024-07-25	H.C. WainwrightEdward White	$21	165.8% upside
2022-11-11	JMP Securities	$30	279.7% upside

Aura Biosciences (AURA) FAQ

Aura Biosciences's target price stands at $18. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $18 for AURA implies 121.5% upside versus today's price ($7.9). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Aura Biosciences's target price evolved across reporting periods, while the comparison chart places AURA next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.